Viatris Inc (VTRS) USD0.01

Sell:$8.77Buy:$8.78$0.04 (0.45%)

NASDAQ:0.32%
Market closed | Prices delayed by at least 15 minutes
Sell:$8.77
Buy:$8.78
Change:$0.04 (0.45%)
Market closed | Prices delayed by at least 15 minutes
Sell:$8.77
Buy:$8.78
Change:$0.04 (0.45%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. It produces oral solid doses, injectables, and products with complex dosage forms.

Key people

Scott A. Smith
Chief Executive Officer, Director
Theodora Mistras
Chief Financial Officer
Paul B. Campbell
Chief Accounting Officer, Corporate Controller
Corinne Le Goff
Chief Commercial Officer
Brian Roman
Chief Legal Officer
Hemanth Varghese
Chief Strategy Officer
Melina E. Higgins
Independent Non-Executive Chairman of the Board
Mark W. Parrish
Lead Independent Vice Chairman of the Board
Rajiv Malik
Director
Rogerio Vivaldi Coelho
Independent Director
Wyllie Don Cornwell
Independent Director
Click to see more

Key facts

  • EPIC
    VTRS
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US92556V1061
  • Market cap
    $10.08bn
  • Employees
    32,000
  • Shares in issue
    1.23bn
  • Exchange
    NASDAQ
  • Index
    S&P 500, TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.